AHNS22
MULTI-INSTITUTIONAL INSIGHT INTO THE PROGNOSTIC SIGNIFICANCE OF LYMPH NODE YIELD AND LYMPH NODE RATIO IN CLINICALLY NODE NEGATIVE EARLY ORAL CAVITY SQUAMOUS CELL CARCINOMA.
Oral Cavity
Nathan Farrokhian, BS, BA1; Andrew Holcomb, MD2; Erin Dimon1; Omar Karadaghy, MD1; Christina Ward1; Erin Whiteford, MS2; Claire Tolan, BA2; Elyse K Hanly, MD, PhD3; Marisa R Buchakjian, MD, PhD3; Brette Harding, MD4; Laura Dooley, MD4; Justin Shinn, MD5; C Burton Wood, MD5; Sarah Rohde, MD5; Sobia Khaja, MD6; Anuraag S Parikh, MD7; Mustafa G Bulbul, MD7; Mark Varvares, MD7; Joseph Penn1; Sarah Goodwin1; Andres M Bur, MD1
1Department of Otolaryngology - Head and Neck Surgery, University of Kansas Medical Center; 2Department of Otolaryngology, Nebraska Methodist Health System; 3Department of Otolaryngology - Head and Neck Surgery, University of Iowa; 4Department of Otolaryngology - Head and Neck Surgery, University of Missouri; 5Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University; 6Department of Otolaryngology - Head and Neck Surgery, University of Minnesota; 7Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear Infirmary
AHNS23
IMPACT OF CLOSEST MARGIN DISTANCE IN ORAL CAVITY SQUAMOUS CELL CARCINOMA PATIENTS
Wenda Ye, MD1; Kevin Guo2; Jean-Nicolas Gallant, MD, PhD1; Madelyn Stevens, MD1; Veerain Gupta2; Kayvon Sharif2; Vivian Weiss, PhD3; Eben Rosenthal, MD1; Young Kim, MD, PhD1; James Netterville, MD1; Kyle Mannion, MD1; Alexander Langerman, MD, SM, FACS1; Sarah Rohde, MD1; Robert Sinard, MD, FACS1; Michael Topf, MD1
1Vanderbilt University Medical Center Department of Otolaryngology - Head and Neck Surgery; 2Vanderbilt University School of Medicine; 3Vanderbilt University Medical Center Department of Pathology, Microbiology, and Immunology
AHNS25
THE IMPACT OF EXTENT OF EXTRANODAL EXTENSION IN ORAL CAVITY SQUAMOUS CELL CARCINOMA: NATIONAL CANCER DATABASE ANALYSIS AND REVIEW OF THE LITERATURE
Brooke Quinton, BS1; Claudia Cabrera, MD, MS2; Akina Tamaki, MD2; Shawn Li, MD2; Nicole Fowler, MD2; Rod Rezaee, MD2; Pierre Lavertu, MD2; Theodore Teknos, MD2; Quintin Pan, PhD2; Jason Thuener, MD2
1Case Western Reserve University School of Medicine; 2Department of Otolaryngology-Head & Neck Surgery, University Hospitals Cleveland Medical Center
AHNS26
THE VALUE OF SECOND OPINIONS ON THYROID NODULE MANAGEMENT PROVIDED VIA DIRECT-TO-CONSUMER TELEMEDICINE SERVICE
Endocrine Surgery
Samuel Dudley, MD; Marion B Gillespie, MD
University of Tennessee Health Science Center
AHNS27
IMPACT OF HOSPITAL SAFETY NET BURDEN ON THYROID CANCER SURVIVAL
Megh Shah, BA; Ryan Jin, BA; Christopher C Tseng, BS; Rushi Patel, BA; Dylan F Roden, MD; Richard C Park, MD
Rutgers New Jersey Medical School
AHNS28
CAN AFIRMA® EXPRESSION ATLAS PROGNOSTICATE SUSPICIOUS AND MALIGNANT THYROID NODULES NODULES?
Will Thedinger, BA; Jagdish Dhingra, MD
Tufts Medical Center
AHNS29
UPDATE ON SAFETY AND OUTCOMES OF 300 CONSECUTIVE TRANSORAL THYROIDECTOMY CASES
Danielle R Trakimas, MD, MSE; Christopher Razavi, MD; Khalid Ali, MD; Lena Chen, BS; Ralph P Tufano, MD; Jonathon O Russell, MD
Johns Hopkins Hospital
AHNS30
OPIOID PRESCRIBING IN PATIENTS UNDERGOING NECK DISSECTION FOR THYROID MALIGNANCY
Jennifer March; James Lim; Maisie Shindo
Oregon Health and Science University
AHNS31
PATIENT COMPLIANCE WITH SURVEILLANCE OF THYROID NODULES CLASSIFIED AS ATYPIA OF UNDETERMINED SIGNIFICANCE
Benjamin K Walters, MD; Travis R Newberry, MD; Alex J Mckinlay, MD
San Antonio Military Medical Center
AHNS32
RISK FACTORS FOR THE DEVELOPMENT OF FISTULA FOLLOWING ORAL CAVITY COMPOSITE RESECTION WITH FREE FLAP RECONSTRUCTION
Jean-Nicolas Gallant1; Wenda Ye1; Madelyn Stevens1; Michael O’Brien2; Ansley Kunnath2; Siddarth Patel2; Margaret Mitchell3; Vivian Weiss1; Eben Rosenthal1; Young Kim1; James Netterville1; Kyle Mannion1; Alexander Langerman1; Sarah Rohde1; Michael Topf1; Robert Sinard1
1Vanderbilt University Medical Center; 2Vanderbilt University; 3Massachusetts Eye and Ear Infirmary
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX